Researchers, providers need to address cancer health care disparities in LGBTQ community
the ONA take:
An article by researchers from the Moffitt Cancer Center describes disparities in cancer care for the Lesbian, Gay, Bisexual, Transgender/Transsexual, Queer/Questioning (LGBTQ) community. Adults in the LGBTQ community tend to be lower economic status and seek health care less often.
In addition, knowledge about cancer in this community is significantly less than what is known about the heterosexual community.
In analyzing the current LGBTQ literature on prevention, early detection, diagnosis, treatment, and survivorship in this community, the researchers found this minority population to be medically underserved.
Incidence and death rates of some cancers are higher for subgroups of LGBTQ patients, such as anal cancer in gay men and cervical cancer in lesbian and bisexual women. Furthermore, data does not reflect the cultural differences in each of these population groups.
The Moffitt researchers recommend all surveys and registries collect information on gender identity and sexual orientation so more comprehensive data is available on the impact of cancer in this community.
The cancer-related needs of the LGBTQ community are a crucial area to be addressed by the health care providers and the research community, explained a senior member of the Health Outcomes and Behavior Program at Moffitt.
Adults in the LGBTQ community tend to be lower economic status and seek health care less often.
Sign Up for Free e-newsletters
- Triplet Regimen Found Most Effective for Relapsed/Refractory Multiple Myeloma
- Integrating Preoperative Oral Care Into Cancer Treatment Plans
- Current Status and Dilemma of Second-line Treatment in Advanced Pancreatic Cancer: Is There a Silver Lining?
- American Association for Cancer Research Releases Its 2018 Annual Report
- Pulmonary Toxicity Increased in Pediatric Hodgkin Lymphoma Treated With Brentuximab Vedotin
- Benefit of Chemotherapy for Breast Cancer Observed With Midrange Gene Assay Score
- Antioxidant Interaction With Cancer Therapy
- Young Survivors of Breast Cancer Report Sexual Quality of Life Declines After Treatment
- Myeloablative Conditioning Effective in AML Secondary to MDS/MPN Prior to Allogeneic HCT
- Insurance Status Influences Overall Survival in Follicular Lymphoma
- Skin Cancer Screening: Are They Effective?
- Metronidazole, Vancomycin Recommended for C Difficile in Pediatric Oncology, HSCT
- CDC: HPV Vaccination Rates on the Rise Among Adolescents
- High-Dose vs Standard-Dose Flu Vaccine in Elderly Receiving Chemotherapy
- FDA Grants Approval to Novel Treatment for Hairy Cell Leukemia
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|